The International Agency for Research on Cancer (IARC) germline TP53 database showed that pancreatic cancer occurred in 1.2% of the affected individuals with a median age of 53 years at the time of diagnosis [43]. This evidence concerns the gene TP53 and pancreatic neoplasm.